Re: Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer. Lehrer S. J Natl Cancer Inst 2026 Jan 8:djaf339. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lehrer S. Re: Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer. J Natl Cancer Inst 2026 Jan 8:djaf339. doi: 10.1093.
PMID: 41507084